P2X7-dependent amplification of therapy efficiency was linked to the facilitation of daunorubicin intracellular load in AML blasts [42], increased cytotoxic activity of temozolomide in glioma cells [153], and enhanced differentiating efficacy of retinoic acid in neuroblastoma cells [44]. This evidence concerns the gene P2RX7 and glioma.